Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001636178-26-000004

CFO AND TREASURER sold 10,000 shares at an average $535.90 ($5,359,005)

  • CFO AND TREASURER acquired 10,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

EDGEMOND JAMES · CFO AND TREASURER

Table I: Non-derivative

10 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-26 Exercise or conversion : show line 1 in the form 10b5-1 +10,000 $135.42 $1,354,200 28,876 D
2026-03-26 Sale : show line 2 in the form 10b5-1 −991 $532.02 $527,236 27,885 D
2026-03-26 Sale : show line 3 in the form 10b5-1 −510 $532.93 $271,794 27,375 D
2026-03-26 Sale : show line 4 in the form 10b5-1 −609 $533.91 $325,153 26,766 D
2026-03-26 Sale : show line 5 in the form 10b5-1 −1,847 $534.98 $988,101 24,919 D
2026-03-26 Sale : show line 6 in the form 10b5-1 −2,003 $535.94 $1,073,491 22,916 D
2026-03-26 Sale : show line 7 in the form 10b5-1 −1,577 $536.90 $846,689 21,339 D
2026-03-26 Sale : show line 8 in the form 10b5-1 −1,149 $537.90 $618,046 20,190 D
2026-03-26 Sale : show line 9 in the form 10b5-1 −994 $538.91 $535,680 19,196 D
2026-03-26 Sale : show line 10 in the form 10b5-1 −320 $540.04 $172,814 18,876 D
Open-market sales · 10,000 sh · avg $535.90 · $5,359,005

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-26 Exercise or conversion : show line 11 in the form 10b5-1 Stock Option −10,000 142,500 D
Loading xslF345X06/primarydocument.xml…